Published in Infect Immun on July 01, 2002
Challenges in homology search: HMMER3 and convergent evolution of coiled-coil regions. Nucleic Acids Res (2013) 1.83
Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun (2008) 1.77
Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun (2006) 1.67
The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Infect Immun (2006) 1.47
A C. trachomatis cloning vector and the generation of C. trachomatis strains expressing fluorescent proteins under the control of a C. trachomatis promoter. PLoS One (2013) 1.32
Chlamydia trachomatis intercepts Golgi-derived sphingolipids through a Rab14-mediated transport required for bacterial development and replication. PLoS One (2010) 1.22
Drosophila melanogaster S2 cells: a model system to study Chlamydia interaction with host cells. Cell Microbiol (2005) 1.20
Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis. PLoS Pathog (2009) 1.18
Site-specific, insertional inactivation of incA in Chlamydia trachomatis using a group II intron. PLoS One (2013) 1.11
Intracellular bacteria encode inhibitory SNARE-like proteins. PLoS One (2009) 1.10
Two coiled-coil domains of Chlamydia trachomatis IncA affect membrane fusion events during infection. PLoS One (2013) 0.89
Use of aminoglycoside 3' adenyltransferase as a selection marker for Chlamydia trachomatis intron-mutagenesis and in vivo intron stability. BMC Res Notes (2015) 0.84
Chlamydia protease-like activity factor (CPAF): characterization of proteolysis activity in vitro and development of a nanomolar affinity CPAF zymogen-derived inhibitor. Biochemistry (2011) 0.84
Establishing homology between mitochondrial calcium uniporters, prokaryotic magnesium channels and chlamydial IncA proteins. Microbiology (2014) 0.79
Emancipating Chlamydia: Advances in the Genetic Manipulation of a Recalcitrant Intracellular Pathogen. Microbiol Mol Biol Rev (2016) 0.79
Chlamydia trachomatis homotypic inclusion fusion is promoted by host microtubule trafficking. BMC Microbiol (2013) 0.78
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13
Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A (1988) 6.54
Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A (1995) 4.18
Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J (1996) 4.02
Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect Immun (1996) 3.67
Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol Microbiol (2000) 2.71
Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. Mol Microbiol (1995) 2.64
A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol (2000) 2.45
Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J Bacteriol (1997) 2.35
The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion. Cell Microbiol (1999) 2.31
Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol Microbiol (2000) 2.21
Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry. Infect Immun (1996) 2.18
Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol Microbiol (1999) 2.18
Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol Microbiol (2001) 2.10
Monoclonal antibodies define genus-specific, species-specific, and cross-reactive epitopes of the chlamydial 60-kilodalton heat shock protein (hsp60): specific immunodetection and purification of chlamydial hsp60. Infect Immun (1992) 1.99
Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery. Mol Microbiol (2001) 1.85
Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect Immun (2000) 1.78
Chlamydia psittaci IncA is phosphorylated by the host cell and is exposed on the cytoplasmic face of the developing inclusion. Mol Microbiol (1997) 1.76
Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates. Infect Immun (1998) 1.75
Fusion of inclusions following superinfection of HeLa cells by two serovars of Chlamydia trachomatis. Infect Immun (1989) 1.68
Temporal analysis of the developing Chlamydia psittaci inclusion by use of fluorescence and electron microscopy. Infect Immun (1996) 1.65
Morphological studies of the association of mitochondria with chlamydial inclusions and the fusion of chlamydial inclusions. J Electron Microsc (Tokyo) (1991) 1.54
Development of a quantitative gene expression assay for Chlamydia trachomatis identified temporal expression of sigma factors. FEBS Lett (1999) 1.51
Some consequences of the multiple infection of cell cultures by TRIC organisms. J Hyg (Lond) (1972) 1.36
Phospholipid composition of purified Chlamydia trachomatis mimics that of the eucaryotic host cell. Infect Immun (1998) 1.28
Genes required for assembly and function of the protein synthetic system in Chlamydia trachomatis are expressed early in elementary to reticulate body transformation. Mol Gen Genet (1997) 1.05
Fusion of Chlamydia trachomatis-containing inclusions is inhibited at low temperatures and requires bacterial protein synthesis. Infect Immun (1998) 0.93
Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol (1982) 4.33
Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii. Proc Natl Acad Sci U S A (1981) 3.91
Differential interaction with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect Immun (1996) 3.67
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A (1992) 3.61
A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A (2004) 3.44
Disulfide-mediated interactions of the chlamydial major outer membrane protein: role in the differentiation of chlamydiae? J Bacteriol (1985) 3.23
Relationship between Energy-dependent Phosphate Uptake and the Electrical Membrane Potential in Lemna gibba G1. Plant Physiol (1981) 3.03
Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol Microbiol (2000) 2.71
Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. Mol Microbiol (1995) 2.64
Directional actin polymerization associated with spotted fever group Rickettsia infection of Vero cells. Infect Immun (1993) 2.59
Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J Cell Biol (1996) 2.49
Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity. Infect Immun (1985) 2.47
Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. J Pediatr (1998) 2.27
Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Infect Immun (1987) 2.25
SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci (1999) 2.21
Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol Microbiol (2000) 2.21
Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med (1998) 2.19
Vesicular interactions of the Chlamydia trachomatis inclusion are determined by chlamydial early protein synthesis rather than route of entry. Infect Immun (1996) 2.18
Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol Microbiol (1999) 2.18
Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol Microbiol (2001) 2.10
IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol (1991) 2.03
Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. Mol Microbiol (2003) 2.03
Alcohol and drug disorders among physically abusive and neglectful parents in a community-based sample. Am J Public Health (1994) 1.96
Identification and properties of chlamydial polypeptides that bind eucaryotic cell surface components. J Bacteriol (1986) 1.93
Nucleoid condensation in Escherichia coli that express a chlamydial histone homolog. Science (1992) 1.87
A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci U S A (1996) 1.87
Reduced postoperative pancreatic fistula rate after pancreatogastrostomy versus pancreaticojejunostomy. J Gastrointest Surg (2008) 1.83
Chlamydia psittaci IncA is phosphorylated by the host cell and is exposed on the cytoplasmic face of the developing inclusion. Mol Microbiol (1997) 1.76
Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol (1993) 1.73
Developmental biology of Coxiella burnettii. Trends Microbiol (1999) 1.65
Temporal analysis of the developing Chlamydia psittaci inclusion by use of fluorescence and electron microscopy. Infect Immun (1996) 1.65
Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg (1996) 1.65
Hypothermia during elective abdominal aortic aneurysm repair: the high price of avoidable morbidity. J Vasc Surg (1995) 1.64
High-risk intrahospital transport of critically ill patients: safety and outcome of the necessary "road trip". Crit Care Med (1995) 1.54
Effects of acid-base correction on hemodynamics, oxygen dynamics, and resuscitability in severe canine hemorrhagic shock. Crit Care Med (1994) 1.54
The Chlamydia trachomatis parasitophorous vacuolar membrane is not passively permeable to low-molecular-weight compounds. Infect Immun (1997) 1.52
Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27). Diabetologia (2012) 1.51
Tandem genes of Chlamydia psittaci that encode proteins localized to the inclusion membrane. Mol Microbiol (1998) 1.48
Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates. Infect Immun (1986) 1.47
Molecular cloning and expression of hctB encoding a strain-variant chlamydial histone-like protein with DNA-binding activity. J Bacteriol (1993) 1.46
Effects of intravenous IL-8 administration in nonhuman primates. J Immunol (1992) 1.44
Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med (1991) 1.44
Acute acalculous cholecystitis. J Am Coll Surg (1995) 1.43
Genetics and regulation of chitobiose utilization in Borrelia burgdorferi. J Bacteriol (2001) 1.41
Effects of pentoxifylline on hemodynamics, oxygen transport, and tissue metabolism in experimental, severe hemorrhagic shock. Crit Care Med (1991) 1.41
Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells. Cell Microbiol (2001) 1.38
Descending aortic cannulation during emergent thoracotomy for blunt traumatic cardiac arrest. J Trauma (1999) 1.38
DNA polymorphism in the conserved 190 kDa antigen gene repeat region among spotted fever group Rickettsiae. Biochim Biophys Acta (1991) 1.35
Hc1-mediated effects on DNA structure: a potential regulator of chlamydial development. Mol Microbiol (1993) 1.35
Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect Immun (2000) 1.34
The 120 kilodalton outer membrane protein (rOmp B) of Rickettsia rickettsii is encoded by an unusually long open reading frame: evidence for protein processing from a large precursor. Mol Microbiol (1991) 1.34
Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase. J Virol (1979) 1.33
Isolation and characterization of a mutant Chinese hamster ovary cell line that is resistant to Chlamydia trachomatis infection at a novel step in the attachment process. Infect Immun (2001) 1.29
A ninth complementation group in xeroderma pigmentosum, XP I. Mutat Res (1985) 1.26
Inhibition of lymphocyte proliferation by factor(s) produced by Schistosoma mansoni. Eur J Immunol (1977) 1.24
Stability of the adenosine 5'-triphosphate pool in Coxiella burnetii: influence of pH and substrate. J Bacteriol (1981) 1.24
Elongation factor Tu resistant to kirromycin in an Escherichia coli mutant altered in both tuf genes. Proc Natl Acad Sci U S A (1977) 1.22
Pollen-based quantitative reconstructions of Holocene regional vegetation cover (plant-functional types and land-cover types) in Europe suitable for climate modelling. Glob Chang Biol (2014) 1.21
Preparation of the FhuA (TonA) receptor protein from cell envelopes of an overproducing strain of Escherichia coli K-12. J Bacteriol (1986) 1.20
Occupational disease in New York State: a comprehensive examination. Am J Ind Med (1989) 1.19
pH dependence of the Coxiella burnetii glutamate transport system. J Bacteriol (1983) 1.18
Estimation of the cytoplasmic pH of Coxiella burnetii and effect of substrate oxidation on proton motive force. J Bacteriol (1983) 1.16
Deoxypyrimidine nucleoside metabolism in varicella-zoster virus-infected cells. J Virol (1978) 1.16
Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol (2001) 1.15
Developmentally regulated synthesis of an unusually small, basic peptide by Coxiella burnetii. Mol Microbiol (1996) 1.14
Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol Microbiol (1998) 1.14
Intestinal sugar transport in experimental diabetes. Diabetes (1981) 1.13
Improving biological control by combining biocontrol agents each with several mechanisms of disease suppression. Phytopathology (2002) 1.12
Induction of cell-associated interleukin 1 through stimulation of the adhesion-promoting proteins LFA-1 (CD11a/CD18) and CR3 (CD11b/CD18) of human monocytes. Eur J Immunol (1990) 1.11
Effect of proteolytic cleavage of surface-exposed proteins on infectivity of Chlamydia trachomatis. Infect Immun (1985) 1.11
The elongation factor Tu binds aminoacyl-tRNA in the presence of GDP. J Biol Chem (1982) 1.09
[Arrhythmias and symptoms during long-term ECG in ambulatory patients]. Schweiz Rundsch Med Prax (1984) 1.09
Terrestrial and aquatic mammals of the Pantanal. Braz J Biol (2011) 1.08
Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants. Infect Immun (2001) 1.08
Spontaneous in vitro malignant transformation in a xeroderma pigmentosum fibroblast line. Int J Cancer (1983) 1.08
Rickettsia rickettsii growth and temperature-inducible protein expression in embryonic tick cell lines. J Med Microbiol (1997) 1.07
Natural autoantibodies and complement promote the uptake of a self antigen, human thyroglobulin, by B cells and the proliferation of thyroglobulin-reactive CD4(+) T cells in healthy individuals. Eur J Immunol (2001) 1.01
Deficiency of the adhesive protein complex lymphocyte function antigen 1, complement receptor type 3, glycoprotein p150,95 in a girl with recurrent bacterial infections. Effects on phagocytic cells and lymphocyte functions. J Clin Invest (1985) 1.01
Biosafety concerns and Coxiella burnetii. Trends Microbiol (1996) 1.00
[Analytical characterization of palatinit (author's transl)]. Z Lebensm Unters Forsch (1979) 1.00
Radical changes to chlamydial taxonomy are not necessary just yet. Int J Syst Evol Microbiol (2001) 0.99
Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c. Scand J Immunol (1988) 0.98
Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes. J Immunol (1987) 0.98
Blood transfusion-induced suppression of cellular immunity in man. Hum Immunol (1980) 0.98
Activated skin mast cells are involved in murine hair follicle regression (catagen). Lab Invest (1997) 0.98
Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor. J Immunol (1986) 0.97
A developmental stage-specific histone H1 homolog of Coxiella burnetii. J Bacteriol (1996) 0.97
Inhibition of complement activation by natural sulfated polysaccharides (fucans) from brown seaweed. Mol Immunol (1994) 0.97
Health costs of occupational disease in New York State. Am J Ind Med (1989) 0.97
One-year survival and neurological outcome after pediatric cardiopulmonary resuscitation. Intensive Care Med (2002) 0.96
Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells. J Immunol (1991) 0.96
Substance use and sexual risk behaviour among HIV-positive men who have sex with men in specialized out-patient clinics. HIV Med (2012) 0.96
Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand J Immunol (1993) 0.96
Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii. Infect Immun (1988) 0.95
Localization of the chaperone domain of FKBP52. J Biol Chem (2001) 0.95
Mouse monoclonal antibodies to the human C3b receptor. Mol Immunol (1985) 0.94
Overproduction of the proFhuA outer membrane receptor protein of Escherichia coli K-12: isolation, properties, and immunocytochemical localization at the inner side of the cytoplasmic membrane. Arch Microbiol (1986) 0.94
Identification of surface molecules on salivary glands of the mosquito, Aedes aegypti, by a panel of monoclonal antibodies. Insect Biochem Mol Biol (1999) 0.94